Drugs / YMB 1002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00099281 | May 2004 → Jun 2006 | breast cancer, metastatic neoplasm | YM BioSciences | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YMB 1002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00099281 ↗ |